Comment on "A small-molecule antivirulence agent for treating Clostridium difficile infection".
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 28003550.
- Also identified by DOI 10.1126/scitranslmed.aad8926.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
New insights into the mechanism of action of ebselen, a small-molecule antivirulence agent that reduces disease pathology in a mouse model of Clostridium difficile infection, suggest a different molecular target may be responsible for its efficacy.
Medical subject headings
- Clostridioides difficile
- Clostridium Infections